Bayer to sell men’s health product Nebido to Grünenthal in €500m deal
Bayer has agreed to sell Nebido (testosterone undecanoate), its men’s health product, to German pharma company Grünenthal for a price of up to €500 million. Nebido, which is used for treating male hypogonadism (testosterone deficiency), is available in more than 80 countries since 2004. Last year, the men’s health product contributed €117 million in sales […]